Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasms × romiplostim × Gynecologic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 2 Thoracic 1 Lymphoid 1 Gynecologic 1

Conditions

Ovarian Neoplasms 2 Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1

Interventions

Paclitaxel 23 Carboplatin 23 pembrolizumab 22 liposomal doxorubicin 11 Cisplatin 10 Bevacizumab 10 Gemcitabine 8 Cyclophosphamide 8 Blood Specimen Collection 8 Topotecan 7 Radiotherapy 7 olaparib 6 Nivolumab 6 Drug Therapy 6 Therapeutics 5 Doxorubicin 5 Dexamethasone 5 pertuzumab 4 pazopanib 4 lenvatinib 4 fludarabine 4 Trastuzumab 4 Surveys and Questionnaires 4 Docetaxel 4 Capecitabine 4 Brachytherapy 4 palbociclib 3 mirvetuximab soravtansine 3 budigalimab 3 atezolizumab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03622931 2021-02-08

TRACEII

Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH

Phase 2 Terminated

Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡